Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
NPJ Biofilms and Microbiomes|December 20, 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIVShilpa Ray, Aswathy Narayanan, Jan Vesterbacka, et al.
European Journal of Immunology|April 21, 2018
IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF<sup>+</sup> innate T cells in the human liverDominic Paquin-Proulx, Benjamin C Greenspun, Lise Pasquet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Prevalence and Risk Factors of Elevated Alanine Aminotransferase (ALT) in 2382 Treatment-naïve HBV/HDV Co-Infected PatientsHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
International Journal of Molecular Sciences|February 13, 2026
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic PatternsÅsa Parke, Benedikt Strunz, Puran Chen, et al.
The Journal of Allergy and Clinical Immunology|October 24, 2024
Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general populationHannes Lindahl, Fredrik Kahn, Åsa Nilsdotter-Augustinsson, et al.
The Journal of Infectious Diseases|May 12, 2021
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population SurveysHassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, et al.
The Journal of Infectious Diseases|July 21, 2022
Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population SurveysHassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, et al.
Blood Advances|February 21, 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron eraPontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan, et al.
Journal of Hepatology|July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtideMaria Buti, Heiner Wedemeyer, Soo Aleman, et al.
Gut|June 17, 2026
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortiaHabiba Kamal, Elisabetta Degasperi, Monica Radu, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
NPJ Biofilms and Microbiomes|December 20, 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIVShilpa Ray, Aswathy Narayanan, Jan Vesterbacka, et al.
European Journal of Immunology|April 21, 2018
IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF<sup>+</sup> innate T cells in the human liverDominic Paquin-Proulx, Benjamin C Greenspun, Lise Pasquet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Prevalence and Risk Factors of Elevated Alanine Aminotransferase (ALT) in 2382 Treatment-naïve HBV/HDV Co-Infected PatientsHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
International Journal of Molecular Sciences|February 13, 2026
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic PatternsÅsa Parke, Benedikt Strunz, Puran Chen, et al.
The Journal of Allergy and Clinical Immunology|October 24, 2024
Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general populationHannes Lindahl, Fredrik Kahn, Åsa Nilsdotter-Augustinsson, et al.
The Journal of Infectious Diseases|May 12, 2021
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population SurveysHassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, et al.
The Journal of Infectious Diseases|July 21, 2022
Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population SurveysHassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, et al.
Blood Advances|February 21, 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron eraPontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan, et al.
Journal of Hepatology|July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtideMaria Buti, Heiner Wedemeyer, Soo Aleman, et al.
Gut|June 17, 2026
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortiaHabiba Kamal, Elisabetta Degasperi, Monica Radu, et al.
Pageof 15